[The publicly listed company Propanc Biopharma announces a plan to acquire 100 million dollars in Ether] The biopharmaceutical company Propanc Biopharma( Nasdaq stock code: PPCB) today( announced on September 2nd) a plan to acquire 100 million dollars worth of Ether within the next 12 months. The company stated that this move will enhance its corporate strategy in various areas such as Crypto Assets investment, drug development, and asset acquisition.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
The publicly traded company Propanc Biopharma announced plans for a $100 million Ethereum acquisition.
[The publicly listed company Propanc Biopharma announces a plan to acquire 100 million dollars in Ether] The biopharmaceutical company Propanc Biopharma( Nasdaq stock code: PPCB) today( announced on September 2nd) a plan to acquire 100 million dollars worth of Ether within the next 12 months. The company stated that this move will enhance its corporate strategy in various areas such as Crypto Assets investment, drug development, and asset acquisition.